ECE2016 Eposter Presentations Diabetes therapy (44 abstracts)
Economic impact on the use of insulin pumps in diabetes type I – analysis on Portuguese real life results
Ines Joaquim 1 , Joana Vilaverde 2 , Luísa Barros 3 , Isabel Diniz 3 , Filipa Sabino 4 , José Manuel Boavida 4 & Helena Cardoso 2
1Portugal, Lisbon, Portugal; 2Centro Hospitalar do Porto, Oporto, Portugal; 3Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; 4Direcção Geral de Saúde, Lisbon, Portugal.
Although, diabetes type I patients in Portugal have complete and free access to HbA1c management (via multiple daily injections) only a few percentage has been provided an insulin pump – priority is given to children and women in fertile age trying to get pregnant. By the end of 2014, 1.150 insulin pumps had already been provided by the National Program of Insulin Pumps, but at least 3.000 patients with indication for insulin pump use were in waiting list. HbA1c pre-pump as well as number of hypoglycaemias and ketoacidosis events have been registered in a database for those patients that were provided an insulin pump. Annual control medical appointments fed this database with post-pump results. Analysis on these results showed important reductions on the number of hypoglycaemias and ketoacidosis events per patient-year (hypo: −1.54; ketoacidosis: −0.05) and a reduction of average HbA1c of these patients by 1%. Collecting Portuguese costs on hypoglycaemia events, ketoacidosis events and main chronic diseases related to diabetes enabled the analysis on the economic impact of the use of insulin pumps on Portuguese patients in a real life setting. Results show that in the short-term, it is expected annual savings of 3.336€ per patient driven by the reduction of acute events. In the long-term, the reduction of the HbA1c significantly reduces the risk of developing chronic diseases saving around 25.553€ per patient. A total of 125.639€ per patient can be saved during 30 years of using an insulin pump. An investment up to 3.585€ per patient per year is possible and justifies the use of insulin pumps given the potential savings per patient that are estimated.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more